Clinical Trial Update: Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial (HIKARI) evaluated the efficacy and safety of Betamethasone Microsphere for macular edema due to branch retinal vein occlusion. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema Due to Branch Retinal Vein Occlusion

Drugs mentioned

• Betamethone Microsphere (betamethasone)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Macular Edema Following Branch Retinal Vein Occlusion | Phase 2, Phase 3 | Status: COMPLETED